We are live on
!
Find out more
KXA
KPCB XII Associates Portfolio holdings
AUM
$738K
1-Year Est. Return
3.15%
This Fund
S&P 500
This Quarter
Est. Return
+14.59%
1 Year Est. Return
-3.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$62.3M
AUM Growth
-$74.9M
(-55%)
Cap. Flow
-$99.3M
Cap. Flow
% of AUM
-159.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$73.5M |
| 2 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$25.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 63.03% |
| 2 | Healthcare | 36.12% |
| 3 | Materials | 0.85% |
Similar funds
TA
LCM
ACP
FG
RCG
FWCM
MVUM
BCIM
KPCB XII Associates's Q1 2019 Portfolio in Review
As of Q1 2019, KPCB XII Associates held 3 positions worth $62.3M, down 55% from $137M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
KPCB XII Associates withdrew a net $99.3M in Q1 2019, reducing 2 holdings. Its largest reduction was Inspire Medical Systems, cutting an estimated $73.5M.
By sector, the portfolio is most concentrated in Technology at 63% of assets, up from 45% a quarter earlier, followed by Healthcare and Materials.
- KPCB XII Associates's biggest Q1 2019 reduction was Inspire Medical Systems, cutting an estimated $73.5M.
- KPCB XII Associates's ten largest holdings make up 100% of its $62.3M portfolio in Q1 2019.
- KPCB XII Associates opened 0 new positions and closed 0 in Q1 2019.
- KPCB XII Associates's portfolio value fell 55% quarter-over-quarter to $62.3M.
Based on KPCB XII Associates's 13F filing for Q1 2019, filed 25 Apr 2019.